Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3

The article recommends five Zacks Rank #1 growth stocks for Q4 after a mixed Q3, citing favorable growth prospects and improving earnings estimates. Quanta Services' backlog reached a record $53.4 billion at June 30, 2026, up 49% year over year; FormFactor reported $85 million in Q2 DRAM revenue, with HBM contributing about two-thirds; and Semtech's Q2 fiscal 2027 data-center sales were a record $100 million, up 91% year over year. Roku's Q2 2026 advertising revenue rose 24.8% to $672.8 million, while the broader outlook cites softer inflation, lower bond yields and crude prices, and potentially less-aggressive Fed rate hikes.

Analysis

The five picks are not five independent growth exposures: PWR, FORM and SMTC all depend to varying degrees on sustained AI-related capital spending. The second-order risk is a synchronized pause in data-center buildouts that first delays orders and utilization, then pressures suppliers’ growth assumptions and valuation multiples. Within that cluster, PWR’s backlog offers a longer-duration visibility signal, but backlog is not cash flow; watch conversion, project timing and labor/capacity constraints rather than treating the headline balance as guaranteed earnings. FORM and SMTC have nearer-term product ramps, so execution or customer timing can hit estimates faster. SMTC’s aggressive quarterly outlook raises the bar: confirmation in reported sales and gross margin matters more than the market-share claims alone.

The macro tailwind is conditional. A rebound in yields or renewed inflation pressure could compress long-duration growth multiples even if near-term orders hold up. Over 1–3 months, earnings and guidance updates are the key catalysts; over 6–18 months, the test is whether AI infrastructure spending converts into durable revenue and cash generation rather than a capex cycle peak.

CNC is a potential diversifier, but triple-digit EPS growth alongside nearly flat revenue makes the quality and source of earnings improvement essential to verify; Medicaid pricing, membership mix and medical-cost trends can reverse margin recovery. ROKU has a distinct advertising-cycle exposure: platform monetization may benefit from streaming migration, but weaker ad budgets or slower rollout of product changes could disappoint. The article supplies no valuation, cash-flow or price data, so it does not support an unconditional buy or precise entry level. Consensus growth framing may underweight execution risk and shared AI-capex concentration.

Key Decisions for Investors

• Avoid equal-weighting the five names as a diversified growth basket. If adding AI-infrastructure exposure, stage entries in PWR, FORM or SMTC rather than chasing all three; size the combined position as one correlated theme.
• Treat SMTC as the highest near-term execution watch: require reported data-center sales and margins to support guidance before adding. A guidance cut or sequential growth materially below the company’s outlook would falsify the near-term ramp thesis.
• For PWR, track backlog conversion, project delays and margin/cash-flow realization over the next few quarters. Slowing conversion despite a large backlog weakens the thesis; sustained conversion supports holding through near-term volatility.
• Keep CNC on a monitor list until filings clarify the drivers of projected EPS growth and show Medicaid rate and medical-cost trends supporting margin recovery. Reversal in those indicators would undermine the recovery case.
• Do not infer a broad Q4 risk-on signal from the article’s rate and inflation view. Reassess growth exposure if Treasury yields reverse higher; for ROKU, verify ad-revenue growth and platform monetization in reported results before treating the streaming shift as a near-term catalyst.